Safety and Efficacy of Hypofractionated Radiotherapy Combined with Tyrosine Kinase Inhibitors in Patients with Lung Metastases after Liver Transplantation for Hepatocellular Carcinoma

被引：0
作者：
Zhuang, Y. [1 ]
Chen, Y. [1 ]
Du, S. [2 ]
Hu, Y. [1 ]
Zeng, Z. C. [1 ]
机构：
[1] Fudan Univ, Zhongshan Hosp, Dept Radiat Oncol, Shanghai, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2789
引用
收藏
页码：E360 / E360
页数：1
相关论文
共 50 条
  • [21] Efficacy of Tumor Markers After Liver Transplantation In Patients With Hepatocellular Carcinoma
    Lee, Tae Yun
    Choi, Ho Joong
    Ahn, Joseph
    Hong, Tae Ho
    You, Young-Kyoung
    TRANSPLANTATION PROCEEDINGS, 2022, 54 (02) : 461 - 467
  • [22] Efficacy and safety of transarterial chemoembolization plus sorafenib in patients with recurrent hepatocellular carcinoma after liver transplantation
    Zhang, Xia
    Cai, Lirong
    Fang, Jian
    Chen, Fengsui
    Pan, Fan
    Zhang, Kun
    Huang, Qian
    Huang, Yuju
    Li, Dongliang
    Lv, Lizhi
    Chen, Man
    Yan, Ruiying
    Lai, Yanhua
    Peng, Yonghai
    Wu, Zhixian
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [23] MANAGEMENT OF BRAIN METASTASES IN PATIENTS WITH RENAL CELL CARCINOMA IN THE ERA OF TYROSINE KINASE INHIBITORS AND STEREOTACTIC RADIOTHERAPY
    Spain, L.
    Stewart, J.
    Campbell, A.
    Lim, A.
    Joon, D. L.
    Weickhardt, A.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 42 - 42
  • [24] Safety and Efficacy of Hypofractionated Radiotherapy With Capecitabine in Elderly Patients With Urothelial Carcinoma
    Leng, Jim
    Akthar, Adil S.
    Szmulewitz, Russell Z.
    O'Donnell, Peter H.
    Sweis, Randy F.
    Pitroda, Sean P.
    Smith, Norm
    Steinberg, Gary D.
    Liauw, Stanley L.
    CLINICAL GENITOURINARY CANCER, 2019, 17 (01) : E12 - E18
  • [25] Safety and Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma: A Single Center Experience
    Pan, Xian
    Wu, Shao-Jie
    Tang, Yi
    Zhou, Yan-Feng
    Luo, Jie-Wei
    Fang, Zhu-Ting
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 883 - 892
  • [26] Impact of Intrahepatic External Beam Radiotherapy in Advanced Hepatocellular Carcinoma Patients Treated with Tyrosine Kinase Inhibitors
    Goh, Myung Ji
    Park, Hee Chul
    Yu, Jeong Il
    Kang, Wonseok
    Gwak, Geum-Youn
    Paik, Yong-Han
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    Sinn, Dong Hyun
    Choi, Moon Seok
    LIVER CANCER, 2023, 12 (05) : 467 - 478
  • [27] Efficacy of tyrosine kinase inhibitors (TKIs) in advanced lung adenosquamous carcinoma
    Hu, M.
    Zhang, B.
    Wang, S.
    Shen, Y.
    Qian, J.
    Zhao, Y.
    Han, B-H.
    ANNALS OF ONCOLOGY, 2019, 30
  • [28] The safety and efficacy of tyrosine kinase inhibitors and programmed cell death protein- 1 inhibitors combined with HAIC/TACE in the treatment of recurrent unresectable hepatocellular carcinoma
    Wei Deng
    Jin Xie
    Tao Wang
    Laihui Luo
    Guoqing Zhu
    Yongqiang Xiao
    Jiahao Tao
    Liucong Lin
    Xian Ge
    Wu Wen
    Minglong Wang
    Bin Yu
    Yu Liu
    Rongguang Luo
    Renhua Wan
    Zhigao Hu
    Renfeng Shan
    BMC Cancer, 25 (1)
  • [29] Efficacy and safety of HAIC combined with tyrosine kinase inhibitors versus HAIC monotherapy for advanced hepatocellular carcinoma: a multicenter propensity score matching analysis
    Yang, Miaomiao
    Jiang, Xiongying
    Liu, Huan
    Zhang, Qingyu
    Li, Jing
    Shao, Li
    Zhao, Lei
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [30] Efficacy of Sorafenib in Patients With Pulmonary Metastatic Hepatocellular Carcinoma after Liver Transplantation
    Chen, Yinghua
    Luo, Wenhui
    Ju, Weiqiang
    He, Xiaoshun
    Zhu, Xiaofeng
    LIVER TRANSPLANTATION, 2014, 20 : S256 - S256
12345